RPG Life Sciences (NSE:RPGLIFE) Short Percentage of Float


NSE:RPGLIFE RPG Life Sciences Ltd NSE:RPGLIFE
92 GF Score
Price ₹2,393.70
GF Value ₹2,364.21
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is RPG Life Sciences Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:RPGLIFE vs ZTS, UTHR: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RPG Life Sciences Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where RPG Life Sciences's Short Percentage of Float falls into.


NSE:RPGLIFE
92GF Score
RPG Life Sciences Ltd NSE:RPGLIFE
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, RPG Life Sciences stock appears to be overvalued. The current stock price of ₹2,393.70 is trading 1.2% above its estimated GF Value™ of ₹2,364.21. GuruFocus considers RPG Life Sciences to be Fairly Valued.

Key valuation signals for NSE:RPGLIFE:

  • Short Percentage of Float:
  • GF Value™: ₹2,364.21 vs. price of ₹2,393.70 (1.2% above fair value)
  • GF Score™: 92/100 with 3 warning signs

No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RPG Life Sciences Business Description

Other Exchanges 532983:India
Address 463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
92GF Score

Get the complete analysis for NSE:RPGLIFE

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,393.70
Price
₹2,364.21
GF Value